Abstract
A 38-year-old woman with membranoproliferative glomerulonephritis type II (MPGN II), previously treated successfully for choroidal neovascular membrane (CNV) in the left eye with injections of anti-vascular endothelial growth factor (VEGF) therapy, subsequently developed blurry vision due to new CNV in her right eye. She was treated with a total of 6 intravitreal injections of ranibizumab, with improvement in acuity and imaging findings. At her most recent follow up visit prior to the writing of this paper, nearly 10 years after her initial presentation with left eye CNV and 7.5 years after developing right eye CNV, she remains recurrence-free.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
